Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ1M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,014
Award facts
- Contract value 100% obligated
- $12,013.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 16, 2026, the Defense Logistics Agency awarded a delivery order valued at $12,013.92 to AmerisourceBergen Drug Corp for the supply of ACTEMRA ACTPEN 162 mg/0.9 mL auto-injector pens. This firm fixed-price delivery order, which is expected to be completed by January 20, 2026, represents a small-value pharmaceutical procurement executed through open competition with no set-aside designation. The award leverages AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of medications and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen). The delivery order will be performed at the company's Conshohocken facility and provides ACTEMRA (tocilizumab), a biologic immunosuppressant used primarily for rheumatoid arthritis and other inflammatory conditions, to support Defense Health Agency and military treatment facility requirements. This procurement is representative of the company's ongoing role as a prime pharmaceutical distributor supplying diverse therapeutic products across specialty medications, generic drugs, and medical devices to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJJ1M?
SPE2DR26FJJ1M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FJJ1M worth?
The government has obligated $12,014 on SPE2DR26FJJ1M.
Is contract SPE2DR26FJJ1M an order under another contract?
Yes. SPE2DR26FJJ1M is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ1M competed?
The extent of competition for SPE2DR26FJJ1M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award